Circulation

SEPTEMBER 2, 2024

Circulation, Volume 150, Issue 10 , Page e224-e225, September 3, 2024.

Preserved Ejection Fraction 45

Preserved Ejection Fraction Quality of Life Article Heart Failure 45

HeartRhythm

SEPTEMBER 4, 2024

Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are comorbid conditions that are increasingly prevalent and have a high socioeconomic burden. This article discusses their shared pathophysiology, focusing on the triad of hypertension, obesity, and aging.We

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Quality of Life 40

American College of Cardiology

JANUARY 6, 2025

In this episode, Andrea Price, MS, AACC hosts Jae Patton, MSN, CRNP, AACC and Sarah Godfrey, MD, MPH to share insights for ensuring quality of life when time is short: tools for the end-stage heart failure care.

Heart Failure 44

Heart Failure Quality of Life Heart Disease Article 44

Journal of Cardiovascular Electrophysiology

JANUARY 30, 2024

Abstract Introduction In hypertrophic cardiomyopathy (HCM), atrial fibrillation (AF) has historically been regarded to have a deleterious impact on clinical course, strongly associated with progressive heart failure (HF) symptoms. Therefore, we evaluated the impact of AF on QoL utilizing patient reported outcome measures (PROMs).

Quality of Life 40

Quality of Life Atrial Fibrillation Cardiomyopathy Heart Failure 40

European Journal of Heart Failure

JANUARY 31, 2024

TAVR in heart failure. ABSTRACT Patients with severe aortic stenosis (AS) may develop heart failure (HF), the presence of which has traditionally been deemed as a final stage in AS progression with poor outcomes. The prognostic covariates and optimal timing of TAVR in patients with less than severe AS remain unclear.

Aortic valve 40

Aortic valve Heart Failure Aortic TAVR 40

International Journal of Cardiovascular Sciences

SEPTEMBER 13, 2023

The disease can cause a variety of symptoms, including heart failure, arrhythmias, peripheral embolism, dysautonomia, angina with normal coronary arteries, and others. The disease can cause a variety of symptoms, including heart failure, arrhythmias, peripheral embolism, dysautonomia, angina with normal coronary arteries, and others.

Article 52

Article Angina Quality of Life Embolism 52

European Journal of Heart Failure

DECEMBER 20, 2023

Abstract Introduction Emerging evidence suggests a beneficial effect of higher heart rates in some patients with heart failure with preserved ejection fraction (HFpEF). This article is protected by copyright. All rights reserved.

Quality of Life 40

Quality of Life Preserved Ejection Fraction Pacemaker Heart Failure 40

European Journal of Heart Failure

SEPTEMBER 26, 2023

Exercise training in patients with advanced heart failure and left ventricular assist device (Ex-VAD) trial. Aims Small studies and observations suggested that exercise training may improve peak oxygen consumption (peakVO 2 ) in patients with advanced heart failure and left ventricular assist device (LVAD).

Exercise 40

Exercise Heart Failure Quality of Life Cardiomyopathy 40

European Journal of Heart Failure

OCTOBER 31, 2023

This 2023 Cochrane review of 60 randomized trials in 8728 heart failure patients, confirms the benefits of participation in exercise-based cardiac rehabilitation (ExCR), including reduced risk of hospitalization and a clinically meaningful improvement in health-related quality of life.

Cardiac Rehabilitation 40

Cardiac Rehabilitation Heart Failure Exercise Quality of Life 40

Frontiers in Cardiovascular Medicine

JUNE 30, 2024

Identifying new targeted therapeutic approaches has become a priority of biomedical research to improve patient outcomes and quality of life. In this article, we first describe how ERK signaling contributes to preserving cardiovascular health.

Cardiovascular Disease 52

Cardiovascular Disease Quality of Life Myocardial Infarction Aneurysm 52

European Journal of Heart Failure

DECEMBER 7, 2023

Increasing severity of obesity is associated with multiple characteristics that may contribute to the development or worsening of heart failure (HF) with preserved ejection fraction (HFpEF). Obesity was associated with more first and recurrent heart failure events. Overall, 60.9% of patients had BMI ≥30 kg/m 2.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Obesity Heart Failure BMI 40

American College of Cardiology

FEBRUARY 1, 2025

Clinicians working with older patients have witnessed firsthand how polypharmacy can complicate both their care and diminish quality of life. Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement from the American Heart Association. had one or more severe potential drug-drug interaction.1

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease CMS Hospital 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 27, 2023

Abstract Continuous flow left ventricular assist devices (CF-LVADs) have been shown to reduce mortality and morbidity in patients with advanced heart failure with reduced ejection fraction. Several questions, however, remain regarding the efficacy of ICD and CRT following CF-LVAD.

Defibrillator 40

Defibrillator Arrhythmia Best Practices Quality of Life 40

American College of Cardiology

MARCH 30, 2025

25 in Chicago and simultaneously published in JAMA.

Heart Failure 50

Heart Failure Quality of Life Hospital Article 50

European Journal of Heart Failure

DECEMBER 22, 2023

Abstract Right-sided heart failure and tricuspid regurgitation are common and strongly associated with poor quality of life and an increased risk of heart failure hospitalizations and death. This article is protected by copyright. All rights reserved.

Heart Failure 75

Heart Failure Tricuspid Cardiovascular Interventions Quality of Life 75

DAIC

FEBRUARY 24, 2025

This article will explore how AI-driven diagnostics are reshaping cardiovascular medicine and how can healthcare leaders can leverage these innovations to improve patient care and control costs. Unplanned cardiac hospitalizations can be very expensive, with studies showing the cost of an index heart failure hospitalization averaging $13,000.

Hospital 52

Hospital Cardiovascular Disease Heart Failure Heart Attack 52

European Journal of Heart Failure

DECEMBER 13, 2023

ABSTRACT Aim Chronic obstructive pulmonary disease (COPD) is common in heart failure with a mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and is associated with worse outcomes. The primary outcome was a composite of cardiovascular death or worsening heart failure. 0.93]; COPD: HR 0.82 [95% CI 0.62–1.10];

Preserved Ejection Fraction 75

Preserved Ejection Fraction Heart Failure Pulmonary Quality of Life 75

Dr. Paddy Barrett

AUGUST 9, 2024

So, if living longer, at a higher quality of life with preserved cognitive capacity is a priority, then exercise has to be on your list. I have discussed this at length in a previous article here. 13 Statins and risks of dementia among patients with heart failure: a population-based retrospective cohort study in Hong Kong.

Dementia 115

Dementia Blood Pressure Obesity Cholesterol 115

European Journal of Heart Failure

OCTOBER 4, 2023

CI, confidence interval; COPD, chronic obstructive pulmonary disease; HF, heart failure; HR, hazard ratio; TIA, transient ischaemic attack. The treatment effect of HIC versus UC on the primary endpoint, 180-day death or heart failure (HF) rehospitalization, was compared by NCC number and by each individual comorbidity.

Heart Failure 40

Heart Failure Hospital Quality of Life Pulmonary 40

Journal of Cardiovascular Electrophysiology

DECEMBER 16, 2024

Clinically meaningful improvements in Atrial Fibrillation Effect on QualiTy-of-life scores were seen at 3 months and were sustained to 12 months postablation, and accompanied with reduction of Class I/III AAD use and DCCV. Central Illustration.

Atrial Fibrillation 40

Atrial Fibrillation Quality of Life Atrial Flutter Ablation 40

American College of Cardiology

OCTOBER 28, 2024

Findings from the TAVR UNLOAD trial found preemptive TAVR was not superior to clinical aortic stenosis surveillance (CASS) for the hierarchical occurrence of all-cause death, disabling stroke, disease-related hospitalizations and heart failure equivalents, and change in quality of life among patients with moderate aortic stenosis (AS) and heart failure (..)

TAVR 58

TAVR Quality of Life Heart Failure Stenosis 58

European Journal of Heart Failure

DECEMBER 1, 2024

5+) support is effective in facilitating heart recovery, overall survival, and quality of life. Methods and results This single-centre retrospective study examined midterm (180 days) outcomes of patients with CS supported by Impella 5+ who achieved heart recovery. The average duration of Impella support was 10.5 ± 8 days.

Cardiogenic Shock 40

Cardiogenic Shock Heart Transplant Outcomes Transplant 40